Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EEXNYSE:EVHNASDAQ:IIINASDAQ:NEO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEEXEmerald$4.68-0.2%$4.14$3.22▼$6.74$930.66M1.05197,640 shs96,919 shsEVHEvolent Health$8.08-5.5%$9.12$7.06▼$33.63$948.59M1.042.41 million shs1.92 million shsIIIInformation Services Group$4.69-3.3%$4.12$2.92▼$5.05$226.08M1.08116,591 shs269,674 shsNEONeoGenomics$7.38-1.3%$8.41$6.08▼$19.12$949.77M1.61.17 million shs1.56 million shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEEXEmerald-0.11%+1.30%+4.35%+19.85%-15.90%EVHEvolent Health-5.61%+5.62%-23.08%-13.26%-63.34%IIIInformation Services Group-3.30%+0.21%+21.19%+51.29%+47.02%NEONeoGenomics-1.34%-0.54%-5.87%-29.98%-44.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEEXEmerald1.462 of 5 stars3.52.00.80.01.20.00.0EVHEvolent Health2.9332 of 5 stars4.52.00.00.01.61.70.6IIIInformation Services Group3.1804 of 5 stars2.54.01.70.01.52.51.9NEONeoGenomics3.6416 of 5 stars4.23.00.00.02.63.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEEXEmerald 3.00Buy$7.9068.80% UpsideEVHEvolent Health 3.00Buy$17.79120.12% UpsideIIIInformation Services Group 3.00Buy$5.5017.27% UpsideNEONeoGenomics 2.45Hold$13.8387.44% UpsideCurrent Analyst Ratings BreakdownLatest III, NEO, EEX, and EVH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral5/13/2025EVHEvolent HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.005/12/2025IIIInformation Services GroupSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/12/2025IIIInformation Services GroupBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$3.75 ➝ $5.505/9/2025EVHEvolent HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.005/6/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$18.00 ➝ $12.005/2/2025EEXEmeraldRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.80 ➝ $7.805/1/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $10.004/30/2025NEONeoGenomicsLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/30/2025NEONeoGenomicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $10.004/30/2025NEONeoGenomicsLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform$25.00 ➝ $9.00(Data available from 6/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEEXEmerald$413.10M2.25$0.69 per share6.83($1.47) per share-3.18EVHEvolent Health$2.40B0.40$1.35 per share6.00$9.38 per share0.86IIIInformation Services Group$242.90M0.93$0.60 per share7.83$2.09 per share2.24NEONeoGenomics$672.36M1.41$0.27 per share27.03$7.02 per share1.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEEXEmerald-$8.20M$0.03N/A∞N/A-5.29%-13.26%-1.92%8/6/2025 (Estimated)EVHEvolent Health-$113.04M-$1.23N/AN/AN/A-2.41%5.73%2.36%8/14/2025 (Estimated)IIIInformation Services Group$6.15M$0.15N/A29.311.34-1.20%4.43%1.83%8/4/2025 (Estimated)NEONeoGenomics-$87.97M-$0.61N/A82.00N/A-11.92%-2.10%-1.17%7/28/2025 (Estimated)Latest III, NEO, EEX, and EVH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025EVHEvolent Health$0.08$0.06-$0.02-$0.63$460.15 million$483.65 million5/1/2025Q1 2025EEXEmerald$0.07$0.08+$0.01$0.08$134.30 million$147.70 million4/29/2025Q1 2025NEONeoGenomics-$0.02-$0.08-$0.06-$0.20$171.38 million$168.04 million3/14/2025Q4 2024EEXEmerald$0.03$0.03N/A$0.03$108.05 million$106.80 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEEXEmerald$0.061.28%N/A200.00%N/AEVHEvolent HealthN/AN/AN/AN/AN/AIIIInformation Services Group$0.183.84%+25.99%120.00%1 YearsNEONeoGenomicsN/AN/AN/AN/AN/ALatest III, NEO, EEX, and EVH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/6/2025IIIInformation Services Groupquarterly$0.04503.9%6/6/20256/6/20256/27/20255/2/2025EEXEmeraldquarterly$0.01501.3%5/12/20255/12/20255/22/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEEXEmerald1.021.271.27EVHEvolent Health0.581.041.04IIIInformation Services Group0.691.971.97NEONeoGenomics0.381.981.91Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEEXEmerald14.90%EVHEvolent HealthN/AIIIInformation Services Group73.10%NEONeoGenomics98.50%Insider OwnershipCompanyInsider OwnershipEEXEmerald4.00%EVHEvolent Health1.40%IIIInformation Services Group15.90%NEONeoGenomics2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEEXEmerald600198.86 million179.64 millionOptionableEVHEvolent Health5,100117.40 million114.70 millionOptionableIIIInformation Services Group1,34048.20 million41.22 millionNot OptionableNEONeoGenomics2,100128.70 million126.79 millionOptionableIII, NEO, EEX, and EVH HeadlinesRecent News About These CompaniesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 4 at 1:45 PM | accessnewswire.comNeoGenomics, Inc. (NASDAQ:NEO) Short Interest Up 32.2% in MayJune 3 at 9:23 PM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zeo Energy Corp. - ZEOJune 3 at 5:00 PM | accessnewswire.comNeoGenomics, Inc. (NASDAQ:NEO) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 1, 2025 | marketbeat.comNuveen Asset Management LLC Sells 98,179 Shares of NeoGenomics, Inc. (NASDAQ:NEO)June 1, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Director Michael Aaron Kelly Purchases 5,000 SharesMay 30, 2025 | marketbeat.comNeoGenomics unveils new oncology diagnostics at ASCO 2025May 29, 2025 | investing.comFort Myers-based NeoGenomics to unveil new cancer diagnostics at ASCO 2025May 29, 2025 | gulfshorebusiness.comNeoGenomics, Inc. (NASDAQ:NEO) Director Buys $38,000.00 in StockMay 29, 2025 | insidertrades.comNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025May 29, 2025 | finance.yahoo.comBrokerages Set NeoGenomics, Inc. (NASDAQ:NEO) PT at $13.83May 27, 2025 | americanbankingnews.comBNP Paribas Financial Markets Sells 35,979 Shares of NeoGenomics, Inc. (NASDAQ:NEO)May 26, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of "Hold" from AnalystsMay 26, 2025 | marketbeat.comNeoGenomics introduces c-MET companion diagnostic for NSCLCMay 23, 2025 | finance.yahoo.comNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung CancerMay 22, 2025 | businesswire.comNeoGenomics to Participate in Upcoming June Investor ConferencesMay 20, 2025 | businesswire.comGraham Capital Management L.P. Acquires 51,626 Shares of NeoGenomics, Inc. (NASDAQ:NEO)May 16, 2025 | marketbeat.comJanus Henderson Group PLC Has $101.60 Million Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO)May 15, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 54,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO)May 15, 2025 | marketbeat.comNeoGenomics (NASDAQ:NEO) Upgraded to Hold at StockNews.comMay 15, 2025 | marketbeat.comInsider Buying: NeoGenomics, Inc. (NASDAQ:NEO) COO Acquires 5,700 Shares of StockMay 14, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingThe Top-Ranked Insider Buys From April by Market CapBy Thomas Hughes | May 6, 2025View The Top-Ranked Insider Buys From April by Market CapJoby Just Flew Two Aircraft at Once—Here’s Why It MattersBy Jeffrey Neal Johnson | May 14, 2025View Joby Just Flew Two Aircraft at Once—Here’s Why It MattersIII, NEO, EEX, and EVH Company DescriptionsEmerald NYSE:EEX$4.68 -0.01 (-0.21%) As of 06/4/2025 03:59 PM EasternEmerald Holding, Inc. operates business-to-business (B2B) trade shows in the United States. The company provides B2B trade show franchises; and B2B print publications and digital media products, which provide industry specific business news and information across various sectors. It also offers B2B e-commerce and digital merchandising solutions to manufacturers and retailers through Elastic Suite and Bulletin platforms. The company serves retail, design, technology, equipment, and safety and security. Emerald Holding, Inc. was incorporated in 2013 and is headquartered in New York, New York.Evolent Health NYSE:EVH$8.08 -0.47 (-5.50%) Closing price 06/4/2025 03:59 PM EasternExtended Trading$8.12 +0.04 (+0.43%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Information Services Group NASDAQ:III$4.69 -0.16 (-3.30%) As of 06/4/2025 04:00 PM EasternInformation Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX to automate the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management; ISG Generative AI; ISG Network Select to streamline and simplify how enterprises build their network solutions; HR technology and transformations; providers-as-a-business services; ISG Digital Engineering; ISG Research; and training-as-a-service. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.NeoGenomics NASDAQ:NEO$7.38 -0.10 (-1.34%) Closing price 06/4/2025 04:00 PM EasternExtended Trading$7.35 -0.03 (-0.35%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy CrowdStrike Stock Dips on Guidance Miss: It May Rebound Fast Guidewire Rockets Higher: A Move Above $300 Is Probable TSMC Joins NVIDIA in UAE Push, Fueling Growth Outlook Intuit's AI Boom: Stock Soaring, But Should Investors Hit Pause? Constellation Energy and Meta Strike Nuclear Deal, Shares Whipsaw Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
